ALXN1720

· Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALXN1720, covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis [Phase 3]